Stay updated on Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; this is a minor versioning change with no user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:28:33.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The revision label in the footer changed from v3.2.0 to v3.3.1. No other content or functional changes were observed.
    Difference
    0.1%
    Check dated 2025-11-24T12:47:04.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The government funding status notice was removed from the page. The core study details, eligibility criteria, and outcomes remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:25:58.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page for NCT02781506. The page content and structure appear unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T01:00:11.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a broad government funding and operating-status notice and updated to v3.2.0. - Removed the specific resource “Clear cell carcinoma of kidney” from Genetic and Rare Diseases Information Center.
    Difference
    3%
    Check dated 2025-10-05T08:18:05.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Terminology refined from "Clear cell renal carcinoma" to "Clear cell carcinoma of kidney" and software/version update to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T03:00:37.000Z thumbnail image

Stay in the know with updates to Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.